Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610467 · ClinicalTrials.gov registry record · NA
Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis
A NA study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00610467 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 2 participants.
The verdict
NCT00610467, a NA study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study investigates whether adding the optical imaging to magnetic resonance imaging can improve the diagnostic specificity of breast cancer.
Interventions
- DEVICE Control Group
- DEVICE Disease Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2006-10-01 |
| Est. Completion | 2017-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610467
The ClinicalTrials.gov registry entry for NCT00610467 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT00610467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00610467 about?
NCT00610467 is a clinical study titled "Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis". This study investigates whether adding the optical imaging to magnetic resonance imaging can improve the diagnostic specificity of breast cancer.
What is the current status of trial NCT00610467?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2006-10-01. Estimated completion is 2017-10-30.
What interventions are being tested in trial NCT00610467?
The interventions under investigation include: Control Group (DEVICE), Disease Group (DEVICE).
Who is sponsoring clinical trial NCT00610467?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.